Machine Learning Analysis Reveals Novel Neuroimaging and Clinical Signatures of Frailty in HIV.


Journal

Journal of acquired immune deficiency syndromes (1999)
ISSN: 1944-7884
Titre abrégé: J Acquir Immune Defic Syndr
Pays: United States
ID NLM: 100892005

Informations de publication

Date de publication:
01 08 2020
Historique:
pubmed: 7 4 2020
medline: 17 2 2021
entrez: 7 4 2020
Statut: ppublish

Résumé

Frailty is an important clinical concern for the aging population of people living with HIV (PLWH). The objective of this study was to identify the combination of risk features that distinguish frail from nonfrail individuals. Machine learning analysis of highly dimensional risk features was performed on a clinical cohort of PLWH. Participants included 105 older (average age = 55.6) PLWH, with at least a 3-month history of combination antiretroviral therapy (median CD4 = 546). Predictors included demographics, HIV clinical markers, comorbid health conditions, cognition, and neuroimaging (ie, volumetrics, resting-state functional connectivity, and cerebral blood flow). Gradient-boosted multivariate regressions were implemented to establish linear and interactive classification models. Model performance was determined by sensitivity/specificity (F1 score) with 5-fold cross validation. The linear gradient-boosted multivariate regression classifier included lower current CD4 count, lower psychomotor performance, and multiple neuroimaging indices (volumes, network connectivity, and blood flow) in visual and motor brain systems (F1 score = 71%; precision = 84%; and sensitivity = 66%). The interactive model identified novel synergies between neuroimaging features, female sex, symptoms of depression, and current CD4 count. Data-driven algorithms built from highly dimensional clinical and brain imaging features implicate disruption to the visuomotor system in older PLWH designated as frail individuals. Interactions between lower CD4 count, female sex, depressive symptoms, and neuroimaging features suggest potentiation of risk mechanisms. Longitudinal data-driven studies are needed to guide clinical strategies capable of preventing the development of frailty as PLWH reach advanced age.

Sections du résumé

BACKGROUND
Frailty is an important clinical concern for the aging population of people living with HIV (PLWH). The objective of this study was to identify the combination of risk features that distinguish frail from nonfrail individuals.
SETTING
Machine learning analysis of highly dimensional risk features was performed on a clinical cohort of PLWH.
METHODS
Participants included 105 older (average age = 55.6) PLWH, with at least a 3-month history of combination antiretroviral therapy (median CD4 = 546). Predictors included demographics, HIV clinical markers, comorbid health conditions, cognition, and neuroimaging (ie, volumetrics, resting-state functional connectivity, and cerebral blood flow). Gradient-boosted multivariate regressions were implemented to establish linear and interactive classification models. Model performance was determined by sensitivity/specificity (F1 score) with 5-fold cross validation.
RESULTS
The linear gradient-boosted multivariate regression classifier included lower current CD4 count, lower psychomotor performance, and multiple neuroimaging indices (volumes, network connectivity, and blood flow) in visual and motor brain systems (F1 score = 71%; precision = 84%; and sensitivity = 66%). The interactive model identified novel synergies between neuroimaging features, female sex, symptoms of depression, and current CD4 count.
CONCLUSIONS
Data-driven algorithms built from highly dimensional clinical and brain imaging features implicate disruption to the visuomotor system in older PLWH designated as frail individuals. Interactions between lower CD4 count, female sex, depressive symptoms, and neuroimaging features suggest potentiation of risk mechanisms. Longitudinal data-driven studies are needed to guide clinical strategies capable of preventing the development of frailty as PLWH reach advanced age.

Identifiants

pubmed: 32251142
doi: 10.1097/QAI.0000000000002360
pii: 00126334-202008010-00012
pmc: PMC7903919
mid: NIHMS1669806
doi:

Substances chimiques

Anti-Retroviral Agents 0

Types de publication

Journal Article Research Support, N.I.H., Extramural Research Support, U.S. Gov't, Non-P.H.S.

Langues

eng

Sous-ensembles de citation

IM

Pagination

414-421

Subventions

Organisme : NINR NIH HHS
ID : R01 NR015738
Pays : United States
Organisme : NIMH NIH HHS
ID : R01 MH114722
Pays : United States
Organisme : NINR NIH HHS
ID : R01 NR014449
Pays : United States
Organisme : FIC NIH HHS
ID : D43 TW009608
Pays : United States
Organisme : NIMH NIH HHS
ID : R01 MH118031
Pays : United States
Organisme : NINR NIH HHS
ID : R01 NR012657
Pays : United States
Organisme : NIMH NIH HHS
ID : R01 MH108559
Pays : United States

Références

Neurosci Biobehav Rev. 2002 May;26(3):353-9
pubmed: 12034135
J Clin Exp Neuropsychol. 2011 Aug;33(7):793-804
pubmed: 21547817
J Clin Invest. 2019 Jul 15;129(8):3339-3346
pubmed: 31305262
AIDS. 2015 May 15;29(8):947-54
pubmed: 25768835
Clin Infect Dis. 2016 Oct 1;63(7):976-83
pubmed: 27358354
Curr HIV/AIDS Rep. 2014 Sep;11(3):279-90
pubmed: 24966138
Neuropsychologia. 1999 Dec;37(13):1499-503
pubmed: 10617270
Top Magn Reson Imaging. 2019 Aug;28(4):189-196
pubmed: 31385898
Cereb Cortex. 2005 Jul;15(7):986-94
pubmed: 15513929
J Acquir Immune Defic Syndr. 2019 Dec 15;82(5):496-502
pubmed: 31714429
Front Aging Neurosci. 2018 Nov 29;10:390
pubmed: 30555318
J Acquir Immune Defic Syndr. 2012 Apr 15;59(5):469-77
pubmed: 22269799
J Gerontol A Biol Sci Med Sci. 2001 Mar;56(3):M146-56
pubmed: 11253156
AIDS Res Hum Retroviruses. 2017 Feb;33(2):157-163
pubmed: 27869500
AIDS. 2020 Apr 1;34(5):737-748
pubmed: 31895148
J Acquir Immune Defic Syndr. 2015 Jun 1;69(2):161-7
pubmed: 26009828
Neuroimage. 2012 Aug 15;62(2):774-81
pubmed: 22248573
Curr HIV/AIDS Rep. 2015 Mar;12(1):16-24
pubmed: 25604237
Assessment. 1999 Jun;6(2):147-78
pubmed: 10335019
Neurology. 2007 Oct 30;69(18):1789-99
pubmed: 17914061
Psychol Methods. 2016 Dec;21(4):583-602
pubmed: 27918183
PLoS One. 2014 Jan 10;9(1):e84217
pubmed: 24427282
PLoS One. 2013 Jul 04;8(7):e68910
pubmed: 23861951
J Anxiety Disord. 2018 Dec;60:35-42
pubmed: 30419537
J Acquir Immune Defic Syndr. 2018 Nov 1;79(3):375-380
pubmed: 29957675
AIDS. 2019 Aug 1;33(10):1603-1611
pubmed: 31305330
Neurobiol Aging. 2014 Apr;35(4):757-68
pubmed: 24216223
J Cereb Blood Flow Metab. 2015 Oct;35(10):1697-702
pubmed: 26036937
Neuroimage. 2012 Feb 1;59(3):2142-54
pubmed: 22019881
Neurology. 2009 Sep 1;73(9):702-8
pubmed: 19720977

Auteurs

Robert H Paul (RH)

Department of Psychological Sciences, University of Missouri, Saint Louis, MO.
Missouri Institute of Mental Health, University of Missouri, Saint Louis, MO.

Kyu S Cho (KS)

Missouri Institute of Mental Health, University of Missouri, Saint Louis, MO.

Patrick Luckett (P)

Department of Neurology, Washington University School of Medicine, Saint Louis, MO; and.

Jeremy F Strain (JF)

Department of Neurology, Washington University School of Medicine, Saint Louis, MO; and.

Andrew C Belden (AC)

Missouri Institute of Mental Health, University of Missouri, Saint Louis, MO.

Jacob D Bolzenius (JD)

Missouri Institute of Mental Health, University of Missouri, Saint Louis, MO.

Jaimie Navid (J)

Department of Neurology, Washington University School of Medicine, Saint Louis, MO; and.

Paola M Garcia-Egan (PM)

Department of Psychological Sciences, University of Missouri, Saint Louis, MO.
Missouri Institute of Mental Health, University of Missouri, Saint Louis, MO.

Sarah A Cooley (SA)

Department of Neurology, Washington University School of Medicine, Saint Louis, MO; and.

Julie K Wisch (JK)

Department of Neurology, Washington University School of Medicine, Saint Louis, MO; and.

Anna H Boerwinkle (AH)

Department of Neurology, Washington University School of Medicine, Saint Louis, MO; and.

Dimitre Tomov (D)

Department of Neurology, Washington University School of Medicine, Saint Louis, MO; and.

Abel Obosi (A)

Missouri Institute of Mental Health, University of Missouri, Saint Louis, MO.
Department of Psychology, University of Ibadan, Ibadan, Nigeria.

Julie A Mannarino (JA)

Missouri Institute of Mental Health, University of Missouri, Saint Louis, MO.

Beau M Ances (BM)

Department of Neurology, Washington University School of Medicine, Saint Louis, MO; and.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH